FDA
approval
· 2021-01-25
FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lifestar Pharma LLC)
Summary
The FDA approved a supplemental application for the combination drug olmesartan medoxomil and hydrochlorothiazide manufactured by Lifestar Pharma LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)